These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2355762

  • 1. [Bone turnover markers in tumor pathology with bone involvement].
    Napal Lecumberri J, Amado Señarís JA, Pesquera C, Riancho JA, González Macías J.
    Med Clin (Barc); 1990 Apr 07; 94(13):487-9. PubMed ID: 2355762
    [Abstract] [Full Text] [Related]

  • 2. [Different behavior of bone turnover markers in endocrine (extrinsic) and structural (intrinsic) osteopathies].
    Napal J, Amado JA, Riancho JA, Freijanes J, Pesquera C, González-Macías J.
    Med Clin (Barc); 1990 Mar 03; 94(8):294-8. PubMed ID: 2342391
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Osteocalcin, a marker in diseases with elevated bone metabolism].
    Stracke H, Schatz C, Pralle H, Ullmann J, Schatz H.
    Dtsch Med Wochenschr; 1985 Sep 20; 110(38):1442-6. PubMed ID: 3875469
    [Abstract] [Full Text] [Related]

  • 9. Biochemical markers of bone turnover: an update.
    van Daele PL, Birkenhäger JC, Pols HA.
    Neth J Med; 1994 Feb 20; 44(2):65-72. PubMed ID: 8208326
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P, Zamagni E, Cellini C, Parente R, Cangini D, Tacchetti P, Perrone G, Ceccolini M, Boni P, Tura S, Baccarani M, Cavo M.
    Eur J Haematol; 2006 May 20; 76(5):399-404. PubMed ID: 16480429
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM.
    J Clin Invest; 1993 Mar 20; 91(3):1138-48. PubMed ID: 8450043
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers].
    de la Piedra Gordo C, Torres Jiménez R.
    An Med Interna; 1990 Oct 20; 7(10):534-8. PubMed ID: 2104101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.